Belbuca

Endo chops sales force after ditching pain drug
BioPharma Dive
Thu, 12/8/16 - 11:15 pm
layoffs
drug reps
Endo International
Belbuca
Why BioDelivery Sciences may benefit from U.S. push to reduce opiod abuse
Bizjournals.com
Thu, 03/3/16 - 10:40 am
BioDelivery Sciences
Bunvail
Belbuca
opioid addiction
Here's how Raleigh's BioDelivery plans to spend $50 million
Bizjournals.com
Mon, 10/26/15 - 09:46 pm
BioDelivery Sciences
R&D
Belbuca
Endo International
BioDelivery's opioid treatment wins FDA approval
Yahoo/Reuters
Mon, 10/26/15 - 08:31 am
FDA
painkillers
opioids
BioDelivery Sciences
Belbuca
Two Biotechs Worth A Look Ahead Of FDA Approvals
Investopedia
Tue, 09/8/15 - 08:57 am
FDA
BioDelivery Sciences
Belbuca
chronic pain
Spectrum Pharmaceuticals
Evomela
Analysts Bullish on BioDelivery Ahead of FDA Event
Investopedia
Tue, 08/18/15 - 09:37 am
BioDelivery Sciences
FDA
Belbuca
chronic pain
BioDelivery: All Eyes On Belbuca
Seeking Alpha
Sat, 08/15/15 - 11:04 am
BioDelivery Sciences
Bunavail
Belbuca
How Raleigh's BioDelivery will use $10M it got from partner on pain drug
Bizjournals.com
Tue, 02/24/15 - 10:07 am
BioDelivery Sciences
Belbuca
Endo Health Solutions